NSW Health Pathology CEO: Patient empowerment, AI, Big Data are trends to watch in healthcare
IN BRIEF
- “Pathology is an integral part of that virtual hospital strategy, […] how we might use technology like point-of-care devices, which are sort of a lab in your hand when we’re out in peoples’ homes, and how do we help monitor patients remotely. We know that the functionality of wearables and biometric devices will certainly help keep people safe in those locations.”
- “What we continue to see is better health outcomes for patients when fast and accurate diagnosis and treatment pathways can be enacted. This includes the advantages that come from precision medicine, using genomics to really understand the cancer types that people have, and the ability to have personalized care, so target therapies deployed for a very specific cancer.”
- "The second area that I think is an important, emerging trend, and I say emerging but it’s here, and it’s real, and it’s growing really rapidly, is how we use AI and deep learning. We’re already seeing the advantages of that in image analysis and large dataset interpretations such as in whole genome sequencing, and it’s really helping to augment our expertise, not replace it.”
In this VISION by Protiviti podcast, we welcome Vanessa Janissen, CEO of New South Wales Health Pathology, where she leads Australia’s largest public pathology and forensic science service. Employing more than 5,000 people, NSW Health Pathology performs over 100,000 clinical and scientific investigations each day across 60 laboratories and more than 150 collection centers. Janissen is interviewed by Ruby Chen, a Director with Protiviti Australia.
In this interview:
1:05 – The digital agenda: Balancing patient privacy with data security
5:01 – The challenges of an aging demographic
8:05 – Strategies for employee wellbeing
13:10 – Pathology’s role in cancer care
18:38 – Emerging trends: Aging, AI, data analytics
Vanessa Janissen is the CEO of NSW Health Pathology where she leads Australia’s largest public pathology and forensic science service. Employing more than 5,000 people, NSW Health Pathology performs over 100,000 clinical and scientific investigations each day across 60 laboratories and 150-plus collection centres. She’s spent over 25 years in healthcare, both in public and private settings, with a deep commitment to serving the community and the strategic pursuit of better outcomes for people. She is also passionate about growing and developing future leaders, particularly championing and supporting women in leadership positions. Previously, Vanessa held a number of leadership positions at Calvary Healthcare, most recently as the National Director, Strategy and Service Development, leading their strategic growth across hospital, aged care, community and virtual care services.
Ruby Chen is a Protiviti director with over 12 years of experience in the financial services industry, for 10 of which she worked within the Big Four banks before transitioning into consulting. She has a broad range of experience providing advisory services and secondments across all three lines of defense.
Did you enjoy this content? For more like this, subscribe to the VISION by Protiviti newsletter.
